Pixilab
Home › Companies › Healthcare › Harbor

Harbor

AI-native CRO for clinical trial operations

Harbor is active in the healthcare space based in San Francisco, CA, USA, founded in 2005.

Profile

Harbor is building an AI-native contract research organization (CRO) for clinical trials. We started with an AI-native system of record for clinical trial data (electronic data capture system), grew the software business to seven trials and ~$187k in contracted software revenue over the next twelve months, then expanded into full-service trial execution and signed our first CRO contract worth $1.93M over three years.

Clinical trials consume 45% of all new drug and device development spend. While some of that goes to software, sites, and patients, the largest line items are services: project management, monitoring, data management, site coordination, source verification, query resolution, record reconciliation, and analysis.

Today, drug and device companies outsource clinical operations to legacy CROs and their massive teams, which is why the CRO market is $82B annually. Harbor delivers the regulated services companies buy from legacy CROs, but built around our AI-native system of record from day one. Our software already automates the core data workflows: study build, data capture, query generation, monitoring, signing, and database lock. Because we own the system of record, we can expand into the surrounding service workflows: site contracting and billing, subject engagement and retention, statistics, reporting, and more.

We built Harbor because we lived through the p

The company sits in the healthcare segment, where it competes on its core product or service.

The company is recorded as being based in San Francisco, CA, USA.

Directory data places it at the Spring 2026 stage.

Its team size is recorded as 2 employees.

Directory analysis

Harbor is an AI-native contract research organization (CRO) that provides end-to-end clinical trial operations, starting with an AI-driven electronic data capture system and expanding into full-service trial execution. The company has secured a multi-year contract worth $1.93 million and has generated $187 k in software revenue from seven trials. Harbor focuses on streamlining the service-intensive aspects of drug and device development, such as project management, monitoring, and data analysis.

Positioning: Harbor operates in the highly specialized clinical trial services market, leveraging AI to differentiate its operational efficiency. Its early traction in software and subsequent CRO contracts indicates a potential niche positioning within the broader clinical research ecosystem.

Note: Harbor is a small, AI-focused CRO headquartered in San Francisco, CA.

Auto-generated directory analysis from public data · updated 7 Oct 2026. Informational only, not investment advice.

SectorHealthcare
HeadquartersSan Francisco, CA, USA
CountryUnited States
Founded2005
Employees2
StageSpring 2026

Website: runharbor.com

Browse related

Contact details and direct channels are available to signed-in members.
Create a free account